Skip to main content
Brian Carney, MD, Hematology, Boston, MA

BrianJamesCarneyMD

Hematology Boston, MA

Assistant Professor of Medicine

Dr. Carney is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Carney's full profile

Already have an account?

  • Office

    330 Brookline Ave
    Boston, MA 02215
    Phone+1 617-677-7000
    Fax+1 617-667-8665

Summary

  • I am an attending physician in the Division of Hematology and Hematologic Malignancies at Beth Israel Deaconess Medical Center and an Assistant Professor of Medicine at Harvard Medical School. The focus of my research is cancer-associated thrombosis, particularly anticoagulation management in patients at high risk for hemorrhage.

Education & Training

  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 2016 - 2019
  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2013 - 2016
  • Tufts University School of Medicine
    Tufts University School of MedicineClass of 2013
  • Providence College
    Providence CollegeClass of 2009

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2013 - 2026
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Lectures

  • Recurrent intracranial hemorrhage and venous thromboembolism following initial intracranial hemorrhage in patients with brain tumors on anticoagulation 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/8/2019
  • Safety of direct-acting oral anticoagulants vs. enoxaparin in patients with primary and metastatic brain tumors 
    60th Annual American Society of Hematology Meeting - San Diego, CA - 12/2/2018

Press Mentions

  • Modified-Dose Anticoagulation in Patients with Cancer, VTE, and Thrombocytopenia
    Modified-Dose Anticoagulation in Patients with Cancer, VTE, and ThrombocytopeniaDecember 1st, 2021

Professional Memberships